ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 9–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Oct 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
November 2025
Nuclear Technology
Fusion Science and Technology
October 2025
Latest News
Nano to begin drilling next week in Illinois
It’s been a good month for Nano Nuclear in the state of Illinois. On October 7, the Office of Governor J.B. Pritzker announced that the company would be awarded $6.8 million from the Reimagining Energy and Vehicles in Illinois Act to help fund the development of its new regional research and development facility in the Chicago suburb of Oak Brook.
Bradley K. Heath, Cody C. Race
Nuclear Technology | Volume 205 | Number 10 | October 2019 | Pages 1369-1377
Technical Note | doi.org/10.1080/00295450.2019.1589853
Articles are hosted by Taylor and Francis Online.
The Resumption of Transient Testing Program was created to re-establish transient testing capability in the United States, specifically at the Transient Reactor Test (TREAT) Facility, located at the Idaho National Laboratory. The restart of TREAT began in early 2014 and concluded in August of 2017. The restart of TREAT occurred 13 months ahead of schedule and $20 million below the $75 million original budget. High-level detail of the restart effort along with several significant factors that contributed to successful restart of TREAT are discussed.
